Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our units, public shares,
public warrants and public rights are each traded on the Nasdaq Global Market under the symbols “NOEM U, ” “ NOEM ”,
“ NOEMW ” and “ NOEMR, ” respectively. Our units commenced public trading on November 22, 2024, and
our public shares, public warrants and public rights commenced separate public trading on January 16, 2025.
Holders
On March 19, 2025, there were
two holders of record of our public units, five holders of record of our common stock, one holder of record of our public warrants, and
one holder of record our public rights.
The number of holders of
record does not include a substantially greater number of “street name’ holders or beneficial holders whose public units,
common stock and public warrants and public rights are held of record by banks, brokers and other financial institutions.
Dividends
We have not paid any cash
dividends on our common stock to date and do not intend to pay cash dividends prior to the completion of our initial business combination.
The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general
financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our
initial business combination will be within the discretion of our board of directors at such time. In addition, our board of directors
is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further, if we incur
any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive
covenants we may agree to in connection therewith.
Securities Authorized for Issuance Under Equity
Compensation Plans
None.
Recent Sales of Unregistered Securities
There have been no sales
of unregistered securities during the quarter ended December 31, 2024, and from the period from January 1, 2025 to the filing date of
this Report which have not previously been disclosed in a Current Report on Form 8-K or Quarterly Report on Form 10-Q.
Purchases of Equity Securities by the Issuer
and Affiliated Purchasers
None.
Use of Proceeds from the Initial Public Offering
On November 22, 2024, the
Company consummated the Initial Public Offering of 6,900,000 units, which included the full exercise by the underwriters of their over-allotment
option in the amount of 900,000 units, at $10.00 per unit, generating gross proceeds of $69,000,000. Simultaneously with the closing
of the Initial Public Offering, the Company consummated the sale of 265,000 private placement units at a price of $10.00 per private
placement unit in a private placement to the sponsor, generating gross proceeds of $2,650,000.
61
Of the gross proceeds received
from the Initial Public Offering and the private placement, an aggregate of $69,000,000 was placed in the trust account. The proceeds
held in the trust account may be invested by the trustee only in U.S. government securities within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a
money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the
Company. The specific investments in our trust account may change from time to time.
We incurred a total of $3,423,710,
consisting of $517,500 of cash underwriting discount, $2,070,000 of deferred underwriting fees, $77,280 fair value of Representative
Shares, and $758,930 of other offering costs.
There has been no material
change in the planned use of proceeds from our Initial Public Offering and the private placement as described in our final prospectus
filed with the SEC pursuant to Rule 424(b) related to the Initial Public Offering.
ITEM 6. [RESERVED]